RADIOTHERAPY AND ONCOLOGY

Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity

Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)

Quantitative evaluation of 4D Cone beam CT scans with reduced scan time in lung cancer patients

Can patient-reported outcomes be used instead of clinician-reported outcomes and photographs as primary endpoints of late normal tissue effects in breast radiotherapy trials? Results from the IMPORT LOW trial

Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial

Is breast seroma after tumour resection associated with patient-reported breast appearance change following radiotherapy? Results from the IMPORT HIGH (CRUK/06/003) trial

Low perfusion compartments in glioblastoma quantified by advanced magnetic resonance imaging and correlated with patient survival

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer

Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data?

The impact of baseline shifts towards the heart after image guidance on survival in lung SABR patients